Clinical trials
Elderly clinical trials
Below are recruiting elderly clinical trials, each written for real people, not researchers. We’re tracking 496 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06964126Recruiting
Gardening for emotional well-being in older adults
This study looks at how gardening activities can improve the mood and social connections of older adults. If you enjoy being outdoors and are able to do light gardening, this trial may be a good fit.
ElâzığAges 65–100 - NCT07125183RecruitingPhase 2
Weekly chemo for advanced leiomyosarcoma in older adults
This trial tests whether weekly doxorubicin is effective and tolerable for people aged 65 and older with advanced or metastatic leiomyosarcoma. It may be a good option if you have not had this type of chemo before.
Aurora, ColoradoAges 65–100 - NCT07114094Recruiting
Developing a tool to safely reduce medications in older adults
This study aims to create and test a tool that helps doctors decide which medications might be safely stopped or reduced for patients aged 60 and older. If you're an older adult visiting a general medicine or family medicine clinic, you may be able to help shape this tool.
Bangalore, KarnatakaAges 60 years+ - NCT07102667Enrolling by invitation
Protein intake for muscle health in older kidney patients
This study tests how much protein older adults with kidney disease and muscle loss should eat to build or maintain muscle. You will follow a protein plan and do simple resistance exercises to see if it helps your strength.
BangkokAges 65 years+ - NCT07093229Enrolling by invitation
Gait analysis for knee arthritis in seniors
This trial studies how walking patterns change in people over 65 with long-term knee osteoarthritis. It aims to understand gait to improve treatment and rehabilitation plans.
CraiovaAges 65–80 - NCT07089641RecruitingPhase 1
Study of ERAS-801 for recurrent or newly diagnosed glioblastoma with EGFR changes
This trial tests an experimental drug called ERAS-801 for people with a type of brain cancer called glioblastoma or gliosarcoma that has a specific genetic change (EGFR amplification or mutation). The study has two groups: one for people whose tumor has come back after treatment, and another for older adults (70+) who are newly diagnosed. The drug targets the EGFR pathway, which may help slow tumor growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07086716Recruiting
Frailty study for hip or knee replacement patients
This study looks at frailty in people who have had a planned hip or knee replacement. It aims to understand how frailty affects recovery.
Rovato, BSAges 18 years+ - NCT05814328Recruiting
Care plan after ER visit to prevent early readmissions
This study tests a “transitional care” plan for people over 75 after they leave the emergency room, aiming to reduce how soon they come back. It may help you get the right support at home and lower the risk of returning to the ER quickly.
ParisAges 75 years+ - NCT06975995Recruiting
Postbiotics for elderly dialysis patients
This trial tests whether postbiotics (helpful substances made by good bacteria) can reduce complications in elderly patients on hemodialysis. If you are 65 or older and have been on dialysis for at least 6 months, this study may help improve your treatment.
Beijing, Beijing MunicipalityAges 65 years+ - NCT07080229RecruitingPhase 3
Nasal spray for blood pressure during cataract surgery in older adults
This trial tests whether a nasal spray of dexmedetomidine can help control blood pressure in older adults with high blood pressure who are having cataract surgery. It may keep your blood pressure more stable during the procedure.
Ismailia, Ismailia GovernorateAges 65 years+ - NCT07077460Recruiting
Hand rehab system with touch feedback from healthy hand
This trial tests a new hand rehabilitation system that uses gentle touch feedback from your healthy hand to guide your recovering hand. It's for healthy adults who can understand basic instructions and have no major health conditions.
Tainan, TaiwanAges 60–80 - NCT07080437Recruiting
Immunotherapy and chemoradiation for elderly esophageal cancer patients
This study looks at how safe and effective a combination of immunotherapy (a treatment that helps your immune system fight cancer) and standard chemotherapy plus radiation is for older adults (70+) with a type of esophageal cancer called squamous cell carcinoma who cannot have surgery or choose not to.
Chongqing, Chongqing MunicipalityAges 70 years+ - NCT06869265RecruitingPhase 2
Thiotepa added to standard chemo before a stem cell transplant for older adults with high-risk AML
This trial tests whether adding a drug called thiotepa to the usual chemotherapy (busulfan and fludarabine) before a half-matched stem cell transplant can safely and effectively treat older adults (55–70) with high-risk AML.
Beijing, Beijing MunicipalityAges 55–70 - NCT05439278RecruitingPhase 3
Radiation schedules plus temozolomide for elderly glioblastoma
This study compares a standard radiation schedule versus a shorter, higher-dose radiation schedule, both with the chemotherapy medicine temozolomide, in older adults with newly diagnosed glioblastoma. It aims to see which approach works better and is practical for people age 70 and older.
SeoulAges 70 years+ - NCT07072195RecruitingPhase 2
A study of AMC6156 for people with muscle loss
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07072208Recruiting
A Study of Four Drugs for Older Adults with DLBCL
This trial tests a combination of four medications (pomalidomide, rituximab, orelabrutinib, and polatuzumab vedotin) for newly diagnosed, elderly patients with diffuse large B-cell lymphoma (DLBCL) who cannot tolerate standard treatments. It aims to see if this combination is effective and safe for older adults.
Suzhou, JiangsuAges 70 years+ - NCT07070336Recruiting
Movement coordination study for older adults
This study tests a special movement program called neuroathletic exercise to see if it helps older adults with balance, walking, and thinking. If you're between 60-80 and not very active, you might be a good fit.
KonyaAges 60–80 - NCT07072988RecruitingPhase 4
Steroid reduction with efgartigimod in older adults with generalized myasthenia gravis
This trial tests if a new drug called efgartigimod can help older adults with generalized myasthenia gravis safely reduce their steroid dose. The goal is to manage the disease with fewer steroid side effects.
Nice, Alpes-MaritimesAges 65 years+ - NCT06940284Recruiting
Food intake and health in hospitalized elderly
This study looks at how much food older adults eat while in the hospital and whether that affects their muscles and recovery. It may help understand the role nutrition plays in staying strong during a hospital stay.
São Paulo, São PauloAges 65 years+ - NCT07060742Recruiting
Exergames for older adults with psychosis
This trial tests if playing specially designed video games (called exergames) can help older adults with psychosis improve their physical and mental health. It may be a good fit if you're 55 or older, have a psychotic disorder, and can stand for a few minutes.
Basel, Canton of Basel-CityAges 55 years+ - NCT07057973Recruiting
Iron therapy before back surgery for elderly with anemia
This trial tests whether giving iron before multi-level lumbar fusion surgery helps improve anemia in older adults. It could be an option if you are 65 or older, have anemia, and are scheduled for this type of back surgery.
Beijing, Beijing MunicipalityAges 60–90 - NCT07061106Recruiting
Balance exercise study for seniors to reduce fall risk
This study tests two types of balance exercises (Otago and Kitchen Sink) in people 65 and older to see if they improve strength, reduce falls, and make daily activities easier.
RawalpindiAges 65–80 - NCT07063199RecruitingPhase 2
Anti-CD38 antibody for older adults with hard-to-treat ITP
This trial tests an investigational antibody (anti-CD38) for older adults with ITP that hasn't improved with standard treatments. The goal is to see if this antibody can safely raise platelet counts and reduce bleeding risk.
Tianjin, Tianjin MunicipalityAges 60 years+ - NCT06989697RecruitingPhase 3
Cilostazol and ginkgo for memory in older adults with diabetes
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Seongnam-siAges 60 years+
Hear when a new Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for elderly?
- Yes. Clin2 currently lists 496 recruiting elderly studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a elderly trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a elderly trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.